M&A news

Penumbra, Inc. Acquires Boston Scientific

Boston Scientific acquired by Penumbra, Inc.

Acquisition$14,500,000,000Hospitals and Health CareUS

Get the full Boston Scientific company profile

Access contacts, investors, buying signals & more

Open in Dashboard
Boston Scientific logo
Acquired

Boston Scientific

United StatesHospitals and Health Care

Deal value

$14,500,000,000

January 16, 2026

Penumbra, Inc. logo
Acquirer

Penumbra, Inc.

Hospitals and Health Care

Penumbra, Inc. has acquired Boston Scientific for $14.5 billion. Boston Scientific, a global medical technology leader with over 40 years of experience, is renowned for transforming lives through innovative medical technologies. The company provides a broad range of high-performance solutions designed to improve patient health, address unmet medical needs, and reduce healthcare costs. Its extensive portfolio encompasses devices and therapies for complex cardiovascular, respiratory, digestive, oncological, neurological, and urological diseases and conditions.

This strategic acquisition significantly expands Penumbra, Inc.'s footprint within the medical technology sector. By integrating Boston Scientific's established global presence and its comprehensive suite of medical devices and therapies, Penumbra aims to broaden its market reach and enhance its capabilities across multiple critical therapeutic areas. The move is designed to leverage Boston Scientific's deep expertise and long-standing relationships within the healthcare community, accelerating Penumbra's growth trajectory and diversifying its product offerings.

The combination of these two entities is expected to generate substantial operational and commercial synergies. The integration will foster innovation by bringing together complementary research and development strengths, leading to the accelerated creation of new, advanced medical solutions. Furthermore, the expanded scale and combined resources are anticipated to improve efficiency, optimize market access, and ultimately provide a more comprehensive and cost-effective array of medical technologies to healthcare providers and patients worldwide.

Looking forward, the unified organization is positioned to deliver enhanced value through a wider range of solutions dedicated to improving patient outcomes and addressing complex global health challenges. This strategic consolidation underscores a shared commitment to advancing medical science and delivering high-impact technologies that benefit patients globally.

No buying signals identified yet.

Unlock GTM signals

Discover Boston Scientific's tech stack and active buying intent.

View GTM signals

Unlock key decision-makers

Get direct access to the decision-makers at Boston Scientific.

Unlock decision-makers